Definition of intervention points in prediabetes

被引:54
作者
Ferrannini, Ele [1 ]
机构
[1] Univ Pisa, Sch Med, Dept Clin & Expt Med, I-56100 Pisa, Italy
关键词
LIFE-STYLE INTERVENTION; IMPAIRED GLUCOSE-TOLERANCE; DIABETES PREVENTION PROGRAM; CORONARY-HEART-DISEASE; FASTING PLASMA-GLUCOSE; INTIMA-MEDIA THICKNESS; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; COST-EFFECTIVENESS; FOLLOW-UP;
D O I
10.1016/S2213-8587(13)70175-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With respect to clinical phenotype and pathophysiology, prediabetes is akin to diabetes. Prediabetes is prevalent in the global population, and those affected are at high risk of progression to overt diabetes, and also at risk of cardiovascular disease (CVD). Progression to diabetes can occur because of worsening insulin resistance, beta-cell dysfunction, or both, but the timecourse can be non-linear and, therefore, unpredictable. Intervention-by lifestyle modification, glucose-lowering drugs, or a combination-can postpone deterioration of glucose control, but effects of intervention are variable and can be transient. Furthermore, to what extent interventions can reduce cardiovascular risk is uncertain. Lifestyle intervention mainly hinges on weight loss; as such, risk of failure in the long-term is high, and implementation at the community level is difficult. The ideal candidate for intervention is an individual with prediabetes-identified by targeted screening-with many well documented cardiovascular risk factors, and who is highly motivated to initiate and maintain multifactorial risk-control using a personalised mix of lifestyle-adaptation and pharmacological treatment.
引用
收藏
页码:667 / 675
页数:9
相关论文
共 97 条
[1]   Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose [J].
Abdul-Ghani, MA ;
Tripathy, D ;
DeFronzo, RA .
DIABETES CARE, 2006, 29 (05) :1130-1139
[2]   Translating the Diabetes Prevention Program into the community - The DEPLOY pilot study [J].
Ackermann, Ronald T. ;
Finch, Emily A. ;
Brizendine, Edward ;
Zhou, Honghong ;
Marrero, David G. .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2008, 35 (04) :357-363
[3]  
[Anonymous], 1999, Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation
[4]  
[Anonymous], 2010, DIABETES CARE, DOI DOI 10.2337/dc10-s062
[5]   Prevalence of Diabetes and Intermediate Hyperglycemia Among Adults From the First Multinational Study of Noncommunicable Diseases in Six Central American Countries The Central America Diabetes Initiative (CAMDI) [J].
Barcelo, Alberto ;
Gregg, Edward W. ;
Gerzoff, Robert B. ;
Wong, Roy ;
Flores, Enrique Perez ;
Ramirez-Zea, Manuel ;
Cafiero, Elizabeth ;
Altamirano, Lesbia ;
Ascencio Rivera, Melanie ;
de Cosio, Gerardo ;
Dinorah de Maza, Martha ;
del Aguila, Roberto ;
Emanuel, Englebert ;
Gil, Enrique ;
Gough, Ethan ;
Jenkins, Valerie ;
Orellana, Patricia ;
Palma, Ruben ;
Palomo, Ruben ;
Pastora, Martha ;
Pena, Rodolfo ;
Pineda, Elia ;
Rodriguez, Bismark ;
Tacsan, Luis ;
Thompson, Loraine ;
Villagra, Lucy .
DIABETES CARE, 2012, 35 (04) :738-740
[6]  
Borg R, 2010, DIABETES, V59, P1585, DOI [10.2337/db10-0777, 10.2337/db09-1774]
[7]   Fatty Liver Index Predicts Further Metabolic Deteriorations in Women with Previous Gestational Diabetes [J].
Bozkurt, Latife ;
Goebl, Christian S. ;
Tura, Andrea ;
Chmelik, Marek ;
Prikoszovich, Thomas ;
Kosi, Lana ;
Wagner, Oswald ;
Roden, Michael ;
Pacini, Giovanni ;
Gastaldelli, Amalia ;
Kautzky-Willer, Alexandra .
PLOS ONE, 2012, 7 (02)
[8]   10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study [J].
Bray, G. A. ;
Chatellier, A. ;
Duncan, C. ;
Greenway, F. L. ;
Levy, E. ;
Ryan, D. H. ;
Polonsky, K. S. ;
Tobian, J. ;
Ehrmann, D. ;
Matulik, M. J. ;
Clark, B. ;
Czech, K. ;
DeSandre, C. ;
Hilbrich, R. ;
McNabb, W. ;
Semenske, A. R. ;
Goldstein, B. J. ;
Smith, K. A. ;
Wildman, W. ;
Pepe, C. ;
Goldberg, R. B. ;
Calles, J. ;
Ojito, J. ;
Castillo-Florez, S. ;
Florez, H. J. ;
Giannella, A. ;
Lara, O. ;
Veciana, B. ;
Haffner, S. M. ;
Montez, M. G. ;
Lorenzo, C. ;
Martinez, A. ;
Hamman, R. F. ;
Testaverde, L. ;
Bouffard, A. ;
Dabelea, D. ;
Jenkins, T. ;
Lenz, D. ;
Perreault, L. ;
Price, D. W. ;
Steinke, S. C. ;
Horton, E. S. ;
Poirier, C. S. ;
Swift, K. ;
Caballero, E. ;
Jackson, S. D. ;
Lambert, L. ;
Lawton, K. E. ;
Ledbury, S. ;
Kahn, S. E. .
LANCET, 2009, 374 (9702) :1677-1686
[9]   Secular Changes in US Prediabetes Prevalence Defined by Hemoglobin A1c and Fasting Plasma Glucose National Health and Nutrition Examination Surveys, 1999-2010 [J].
Bullard, Kai McKeever ;
Saydah, Sharon H. ;
Imperatore, Giuseppina ;
Cowie, Catherine C. ;
Gregg, Edward W. ;
Geiss, Linda S. ;
Cheng, Yiling J. ;
Rolka, Deborah B. ;
Williams, Desmond E. ;
Caspersen, Carl J. .
DIABETES CARE, 2013, 36 (08) :2286-2293
[10]   Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial [J].
Chiasson, JL ;
Josse, RG ;
Gomis, R ;
Hanefeld, M ;
Karasik, A ;
Laakso, M .
LANCET, 2002, 359 (9323) :2072-2077